Thank you very much.
I will note something just to get ahead of some of the questions that will come, so that it doesn't continue to be an issue. It was referenced as well in some of the letters we received.
The motion before this committee is to maintain these documents in camera. That is to keep them secret. I will correct those who refer to this as being a public release of any sensitive documents. I just wanted to lay this out because it came up several times in several of the letters. I thought it should be corrected.
I will now turn to our last witness who is presenting.
Mr. Baylet from Sanofi, you have the floor for five minutes.